Pelkonen R, Koivisto V, Mustajoki P
Acta Endocrinol Suppl (Copenh). 1985;272:49-55. doi: 10.1530/acta.0.110s049.
The major problems with one or two daily subcutaneous injections of fast and intermediate acting insulins are morning hyperglycaemia and nocturnal hypoglycaemia. These problems can be avoided to a great extent by giving a third injection at bedtime. However, the kinetics of plasma free insulin during these insulin regimens is unphysiological and appropriate meal related plasma insulin peaks cannot be achieved. The new intensified methods of insulin delivery, multiple daily injections (MDI) and continuous subcutaneous insulin infusion (CSII) are more physiological. Consequently, a near normal glycaemic control can be achieved with these regimens; more often with CSII than with MDI. The risk of complications of CSII is on the other hand slightly greater. The importance and need of intensified insulin therapy in the treatment of insulin dependent diabetes is not yet fully settled. At the present it is not a primary form of treatment and indicated only if the conservative insulin regimens fail.
每日皮下注射一或两次速效和中效胰岛素的主要问题是清晨高血糖和夜间低血糖。通过在睡前进行第三次注射,这些问题在很大程度上可以避免。然而,在这些胰岛素治疗方案中,血浆游离胰岛素的动力学是非生理性的,无法实现与进餐相关的适当血浆胰岛素峰值。新的强化胰岛素给药方法,即多次皮下注射(MDI)和持续皮下胰岛素输注(CSII),更符合生理情况。因此,采用这些治疗方案可以实现接近正常的血糖控制;通常CSII比MDI更能达到这种效果。另一方面,CSII的并发症风险略高。强化胰岛素治疗在胰岛素依赖型糖尿病治疗中的重要性和必要性尚未完全确定。目前,它不是主要的治疗形式,仅在保守的胰岛素治疗方案失败时才使用。